FDA, USPTO Heads Look At Teaming Up On Drug Pricing
Amid congressional calls for the U.S. Patent and Trademark Office and the U.S. Food and Drug Administration to work more closely on generic-drug matters, leaders at both agencies said Wednesday that...To view the full article, register now.
Already a subscriber? Click here to view full article